How clinical trials of myasthenia gravis can inform pre-clinical drug development.

Authors

Anna Rostedt Punga
Henry J. Kaminski, George Washington UniversityFollow
David P. Richman
Michael Benatar

Document Type

Journal Article

Publication Date

1-13-2015

Journal

Experimental Neurology

Volume

270

Inclusive Pages

78-81

DOI

10.1016/j.expneurol.2014.12.022

Keywords

Disease Models, Animal; Drug Evaluation, Preclinical--methods; Myasthenia Gravis; Research Design--standards

Comments

PMCID: PMC4466144 [Available on 2016-08-01]

APA Citation

Rostedt Punga, A., Kaminski, H. J., Richman, D. P., & Benatar, M. (2015). How clinical trials of myasthenia gravis can inform pre-clinical drug development. Experimental Neurology, 270, 78-81.

Peer Reviewed

1